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In late April, President Carlos Menem buckled under intense pressure from the US government
and partially vetoed a new law approved by the legislature that would have updated regulations
regarding protection of intellectual property rights. The US maintained that the proposed law
would not adequately protect patent rights for multinational pharmaceutical companies, and
the Office of the US Trade Representative (USTR) threatened to impose trade sanctions if the
Menem administration did not veto the bill. Since 1993, when the USTR placed Argentina on a
list of countries that do not adequately protect intellectual property rights, the US and Argentine
governments have been at odds over appropriate laws to respect the patents of multinational
companies (see NotiSur, 04/01/93, 05/06/93, and 11/17/94).
Argentina has a patent rights law in effect that dates back to 1864. That law protects copyrights,
trademarks, and the patents of inventions and processes, but it does not extend protection to
pharmaceutical products, nor to some other goods and services. As a result, the US has been
pushing the government since 1991 to draw up special legislation that would update the 1864
law. In particular, the US wants internationally accepted legal rules in place that would protect
the rights of foreign drug companies, which have been lobbying heavily for appropriate patent
laws in Argentina and in neighboring Brazil (see NotiSur, 04/22/93, 05/13/93, and 06/03/93). The
multinational corporations say they are losing an average of US$500 million per year due to
bootlegged merchandise by Argentine drug companies that are legally free to sell pharmaceutical
goods on the local market without providing any compensation to the companies that developed
the products. Drug sales in Argentina total about US$4.5 billion per year, and Argentine companies
control about 57% of the market because of the lack of patent protection.
The Menem administration submitted a bill to Congress in 1992, but the proposed legislation
remained stalled until mid- 1994, when pressure from the US and some European countries
especially Germany and Great Britain forced the Menem administration to launch an aggressive
lobbying campaign in the legislature to pass the bill. In November 1994, the Senate finally gave
its approval, and then passed the bill on to the Chamber of Deputies. At the end of March, the
Chamber as well gave its stamp of approval, but the deputies added a series of amendments to the
original bill. The full legislature passed the amended version on March 30, which was then sent to
the executive to be signed into law. The amendments, however, were harshly criticized by the US
government and the European Union (EU) as gross violations of the General Agreement on Tariffs
and Trade (GATT).
Three provisions particularly rankled foreign governments and corporations:
-First, a stipulation that prohibits patents for imported drugs, thereby forcing multinationals to set
up local operations in Argentina to qualify for patent protection.
©2011 The University of New Mexico,
Latin American & Iberian Institute
All rights reserved.

Page 1 of 3

LADB Article Id: 56136
ISSN: 1060-4189

-Second, permission for local drug companies to receive licenses to manufacture pharmaceuticals
if foreign corporations have not set up their own domestic operations to produce those products.
By granting such licenses, the Argentine government would in effect be forcing multinational
corporations to accept minimal royalties for the sale of their goods, impeding the ability of foreign
companies to negotiate adequate compensation through normal franchise agreements.
-Third, an eight-year grace period before the new patent law took effect, thus allowing domestic
drug companies to continue to market bootlegged products until the year 2003. The US and
the EU claimed that this last provision directly violated the GATT accords on pharmaceutical
products. GATT rules allow "least developed countries" (LDC) a 10-year transition period for
domestic industries to modernize their enterprises before being forced to compete openly with the
multinationals.
The Argentine pharmaceutical industry which markets its products in Europe and other countries
is estimated to be the thirteenth largest in the world. Thus, the US and the EU argue that Argentina
cannot qualify for the LDC status, and must therefore impose patent legislation immediately. "Such
regulations are only applicable to countries such as Burundi and Surinam," said US Ambassador
to Argentina James Cheek. "These kinds of regulations are not going to attract even one new peso
of investment in Argentina." In fact, the proposed legislation generated a diplomatic row between
the Argentine and US governments. In testimony before the US Senate in early April, US Trade
Representative Mickey Kantor warned that if President Menem signed the bill into law, the US
government would be forced to impose retaliatory trade sanctions against Argentina.
In addition, US Senate majority leader Bob Dole (R-KS) sent a protest letter to the Argentine
ambassador in Washington in which he called the proposed bill "unacceptable piracy." Although
in much softer language, the EU ambassador to Argentina, Pieter Oldekop, also sent a protest note
to the Argentine Foreign Ministry that outlined six amendments in the proposed legislation that
would directly violate GATT accords if President Menem signed the bill into law. Not surprisingly,
such foreign pressures generated an energetic nationalist reaction in the Argentine legislature.
The Chamber of Deputies' Industry Commission which nearly declared US Ambassador Cheek
"persona non grata" because of his public declarations and lobbying efforts sent a formal protest
note to the USTR that emphasized that the Argentine Congress's job is to safeguard Argentine
interests.
"The interests of the Argentine people are what motivate this legislature to act, and the sovereign
decisions taken here are not open to the acceptance or rejection of foreign countries or officials,"
read the letter. Although from the beginning the Menem administration had criticized the
amendments that the Chamber of Deputies had added to the bill, the president vacillated over
vetoing the legislation until the end of April, in large part because the governing Partido Justicialista
feared that it could lose votes in the May 14 general elections if the president appeared to cave in to
foreign pressures (see NotiSur - Latin American Political Affairs, 04/21/95). Nevertheless, the issue
caused a huge internal conflict in the Menem cabinet, with Foreign Minister Guido di Tella and
Economy Minister Domingo Cavallo lobbying for the president to veto the bill. In the end, Menem
sent the bill back to the legislature for review after vetoing only the most controversial amendments,
rather than the entire piece of legislation. Apparently, fear that US trade sanctions would encourage
capital flight by foreign investors weighed heavily on the government, since Argentina is struggling
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to recover from the ripple effects of the Mexican financial crisis (see NotiSur, 02/23/95 and 03/16/95).
"If the US takes this position and Europe as well, what can we do?" said Menem.
"Our legislators and all Argentines have to consider the impact of this bill. If we become isolated
once more because of this situation, we will not just have serious international problems, but huge
repercussions domestically as well." Still, influential legislators are lobbying to muster the twothirds margin necessary for a congressional override of the veto. "Argentina cannot and will not
cede to foreign pressures," said Eduardo Menem, president of the Senate. "US and EU officials must
understand that this issue is beyond the control of the executive. The legislature's legal mandate
is to pass laws that are in the interest of the Argentine people." [Sources: La Jornada (Mexico),
04/06/95; Financial Times, 04/07/95; Notimex, 04/07/95, 04/08/95; Agence France- Presse, 03/30/95,
04/05/95, 04/08/95, 04/10/95; New York Times, 04/19/95; Associated Press, 04/19/95, 04/20/95; Reuter,
04/08/95, 04/19/95, 04/21/95; United Press International, 04/24/95]

-- End --

©2011 The University of New Mexico,
Latin American & Iberian Institute
All rights reserved.

Page 3 of 3

